Anticoagulant use for the prevention of stroke in patients with atrial fibrillation: findings from a multi-payer analysis

Abstract

The AQuIA provided a consistent platform for analysis across multiple AF populations with varying baseline characteristics. Analyzer results show that many high-risk AF patients in selected commercial, Medicare-eligible, and Medicaid populations do not receive appropriate thromboprophylaxis, as recommended by treatment guidelines.